{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:43:06Z","timestamp":1769020986475,"version":"3.49.0"},"reference-count":33,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.3892\/mco.2017.1345","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T03:48:20Z","timestamp":1500954500000},"page":"435-442","source":"Crossref","is-referenced-by-count":10,"title":["Perioperative safety analysis of transcatheter arterial chemoembolization for hepatocellular carcinoma patients with preprocedural leukopenia or thrombocytopenia"],"prefix":"10.3892","volume":"7","author":[{"given":"Lin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Wu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Dong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Zi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,7,25]]},"reference":[{"key":"key20180107151226_b1-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"key20180107151226_b2-mco-0-0-1345","first-page":"51","article-title":"Management of hepatocellular carcinoma","volume":"100","author":"Said","year":"2009","journal-title":"Minerva Med"},{"key":"key20180107151226_b3-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomized controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"key20180107151226_b4-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"key20180107151226_b5-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer: EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"key20180107151226_b6-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"480650","DOI":"10.5402\/2012\/480650","article-title":"Transcatheter arterial chemoembolization: History for more than 30 Years","volume":"2012","author":"Guan","year":"2012","journal-title":"ISRN Gastroenterol"},{"key":"key20180107151226_b7-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/00004836-200211002-00008","article-title":"Minimally invasive image-guided therapies for hepatocellular carcinoma","volume":"35","author":"Goldberg","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"key20180107151226_b8-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12876-015-0329-8","article-title":"Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis","volume":"15","author":"Siriwardana","year":"2015","journal-title":"BMC Gastroenterology"},{"key":"key20180107151226_b9-mco-0-0-1345","first-page":"5159","article-title":"Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver","volume":"30","author":"Poggi","year":"2010","journal-title":"Anticancer Res"},{"key":"key20180107151226_b10-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jss.2014.12.021","article-title":"Prognostic value of the platelet to lymphocyte ratio change in liver cancer","volume":"194","author":"Peng","year":"2015","journal-title":"J Surg Res"},{"key":"key20180107151226_b11-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N Engl J Med"},{"key":"key20180107151226_b12-mco-0-0-1345","first-page":"1141","article-title":"People's Republic of China Ministry of Health: Guideline for the diagnosis and treatment of primary liver cancer (2011)","volume":"27","year":"2011","journal-title":"J Clinical Hepatol"},{"key":"key20180107151226_b13-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"960628","DOI":"10.1155\/2014\/960628","article-title":"Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopenia","volume":"2014","author":"Ooka","year":"2014","journal-title":"Biomed Res Int"},{"key":"key20180107151226_b14-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0033-1333648","article-title":"Chemoembolization of hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2013","journal-title":"Semin Intervent Radiol"},{"key":"key20180107151226_b15-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00508-011-0056-2","article-title":"Austrian Joint \u00d6GGH-\u00d6GIR-\u00d6GHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma","volume":"124","author":"Peck-Radosavljevic","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"key20180107151226_b16-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.4254\/wjh.v7.i16.2009","article-title":"Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients","volume":"7","author":"Facciorusso","year":"2015","journal-title":"World J Hepatol"},{"key":"key20180107151226_b17-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: The BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"key20180107151226_b18-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"e7070","DOI":"10.5812\/hepatmon.7070","article-title":"Safety and efficacy of transcatheter arterial chemoemboliazation in the real-life management of unresectable hepatocellular carcinoma","volume":"13","author":"Mazioti","year":"2013","journal-title":"Hepat Mon"},{"key":"key20180107151226_b19-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cgh.2009.02.021","article-title":"Incidence, prevalence, and clinical significance of abnormal hematologic incidences in compensated cirrhosis","volume":"7","author":"Qamar","year":"2009","journal-title":"Clin Gastroenterology Hepatol"},{"key":"key20180107151226_b20-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1365-2036.2006.02889.x","article-title":"Review article: Thrombocytopenia in chronic liver disease and pharmacologic treatment options","volume":"23","author":"Giannini","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180107151226_b21-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jcp.30.4.367","article-title":"Platelet dynamics in chronic liver disease with special reference to the role of the spleen","volume":"30","author":"Tohill","year":"1977","journal-title":"Clin Pathol"},{"key":"key20180107151226_b22-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1572-0241.2005.41543.x","article-title":"The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis","volume":"100","author":"Rios","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"key20180107151226_b23-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s00535-011-0407-9","article-title":"A retrospective cohort study of partial splentic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia","volume":"46","author":"Tahara","year":"2011","journal-title":"J Gastroenterology"},{"key":"key20180107151226_b24-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/hepr.12222","article-title":"Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve","volume":"44","author":"Ishikawa","year":"2014","journal-title":"Hepatology Res"},{"key":"key20180107151226_b25-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1007\/s00270-010-9983-y","article-title":"Acute thrombocytopenia: An unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization","volume":"34","author":"Poggi","year":"2011","journal-title":"Cardiovasc Intervent Radiol"},{"key":"key20180107151226_b26-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1148\/radiol.2483071902","article-title":"Nonresectable hepatocellular carcinoma: Long-term toxicity in patients treated with transarterial chemoembolization-single-center experience","volume":"249","author":"Buijs","year":"2008","journal-title":"Radiology"},{"key":"key20180107151226_b27-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00270-002-1942-9","article-title":"A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett)","volume":"25","author":"Michalis","year":"2002","journal-title":"Cardiovasc Intervent Radiol"},{"key":"key20180107151226_b28-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jcin.2009.07.016","article-title":"A randomized comparison of transradial versus transfemoral approach for coronary angiography and angioplasty","volume":"2","author":"Brueck","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"key20180107151226_b29-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3892\/ol.2015.3232","article-title":"Acute thrombocytopenia: An uncommon complication occurring following transarterial chemoembolization in a patient with neuroendocrine hepatic metastases","volume":"10","author":"Xie","year":"2015","journal-title":"Oncol Lett"},{"key":"key20180107151226_b30-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0168-8278(94)80105-3","article-title":"The use of granulocyte-macrophage colony-stimulating factor to enhance hematologic parameters of patients with cirrhosis and hypersplensim","volume":"21","author":"Gurakar","year":"1994","journal-title":"J Hepatol"},{"key":"key20180107151226_b31-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2214\/AJR.12.9630","article-title":"Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: Frequency and risk factors","volume":"200","author":"Woo","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"key20180107151226_b32-mco-0-0-1345","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1051-0443(07)61577-2","article-title":"Risk factors for liver abscess formation after hepatic chemoembolization","volume":"12","author":"Kim","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"key20180107151226_b33-mco-0-0-1345","first-page":"259","article-title":"Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: Evaluation of tumor response, toxicity and survival","volume":"6","author":"Kirchhoff","year":"2007","journal-title":"Hepatobiliary Pancreat Dis Int"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T11:06:22Z","timestamp":1569927982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2017.1345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,25]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,7,25]]},"published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.3892\/mco.2017.1345"],"URL":"https:\/\/doi.org\/10.3892\/mco.2017.1345","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,25]]}}}